Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke

Data are limited on the ability of dipyridamole to additionally inhibit platelet function/reactivity in ischaemic cerebrovascular disease (CVD) patients on aspirin.

Source: Journal of the Neurological Sciences - July 11, 2022 Category: Neurology Authors: S.T. Lim, S.J.X. Murphy, S.M. Murphy, T. Coughlan, D. O'Neill, S. Tierney, B. Egan, D.R. Collins, A.J. McCarthy, S.-Y. Lim, D.R. Smith, D. Cox, D.J.H. McCabe Source Type: research